Cargando…
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890184/ https://www.ncbi.nlm.nih.gov/pubmed/33613258 http://dx.doi.org/10.3389/fnsyn.2021.622405 |
_version_ | 1783652462706556928 |
---|---|
author | Tunisi, Lea D'Angelo, Livia Fernández-Rilo, Alba Clara Forte, Nicola Piscitelli, Fabiana Imperatore, Roberta de Girolamo, Paolo Di Marzo, Vincenzo Cristino, Luigia |
author_facet | Tunisi, Lea D'Angelo, Livia Fernández-Rilo, Alba Clara Forte, Nicola Piscitelli, Fabiana Imperatore, Roberta de Girolamo, Paolo Di Marzo, Vincenzo Cristino, Luigia |
author_sort | Tunisi, Lea |
collection | PubMed |
description | Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexinergic LH output area with functional effects on dopaminergic signaling at the mesolimbic circuit. By confocal and correlative light and electron microscopy (CLEM) morphological studies coupled to molecular, biochemical, and pharmacological approaches, we investigated OX-A-mediated dopaminergic signaling at the LH-VTA-nucleus accumbens (NAc) pathway in obese ob/ob mice compared to wild-type (wt) lean littermates. We found an elevation of OX-A trafficking and release to the VTA of ob/ob mice and consequent orexin receptor-1 (OX1R)-mediated over-activation of dopaminergic (DA) neurons via phospholipase C (PLC)/diacylglycerol lipase (DAGL-α)-induced biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). In fact, by retrograde signaling to cannabinoid receptor type 1 (CB1R) at inhibitory inputs to DA neurons, 2-AG inhibited GABA release thus inducing an increase in DA concentration in the VTA and NAc of ob/ob mice. This effect was prevented by the OX1R antagonist SB-334867 (30 mg/Kg, i.p.), or the CB1R antagonist AM251 (10 mg/Kg, i.p.) and mimicked by OX-A injection (40 μg/Kg, i.p.) in wt lean mice. Enhanced DA signaling to the NAc in ob/ob mice, or in OX-A-injected wt mice, was accompanied by β-arrestin2-mediated desensitization of dopamine D2 receptor (D2R) in a manner prevented by SB-334867 or the D2R antagonist L741 (1.5 mg/Kg, i.p.). These results further support the role of OX-A signaling in the control of neuroadaptive responses, such as compulsive reward-seeking behavior or binge-like consumption of high palatable food, and suggest that aberrant OX-A trafficking to the DA neurons in the VTA of ob/ob mice influences the D2R response at NAc, a main target area of the mesolimbic pathway, via 2-AG/CB1-mediated retrograde signaling. |
format | Online Article Text |
id | pubmed-7890184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78901842021-02-19 Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice Tunisi, Lea D'Angelo, Livia Fernández-Rilo, Alba Clara Forte, Nicola Piscitelli, Fabiana Imperatore, Roberta de Girolamo, Paolo Di Marzo, Vincenzo Cristino, Luigia Front Synaptic Neurosci Neuroscience Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexinergic LH output area with functional effects on dopaminergic signaling at the mesolimbic circuit. By confocal and correlative light and electron microscopy (CLEM) morphological studies coupled to molecular, biochemical, and pharmacological approaches, we investigated OX-A-mediated dopaminergic signaling at the LH-VTA-nucleus accumbens (NAc) pathway in obese ob/ob mice compared to wild-type (wt) lean littermates. We found an elevation of OX-A trafficking and release to the VTA of ob/ob mice and consequent orexin receptor-1 (OX1R)-mediated over-activation of dopaminergic (DA) neurons via phospholipase C (PLC)/diacylglycerol lipase (DAGL-α)-induced biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). In fact, by retrograde signaling to cannabinoid receptor type 1 (CB1R) at inhibitory inputs to DA neurons, 2-AG inhibited GABA release thus inducing an increase in DA concentration in the VTA and NAc of ob/ob mice. This effect was prevented by the OX1R antagonist SB-334867 (30 mg/Kg, i.p.), or the CB1R antagonist AM251 (10 mg/Kg, i.p.) and mimicked by OX-A injection (40 μg/Kg, i.p.) in wt lean mice. Enhanced DA signaling to the NAc in ob/ob mice, or in OX-A-injected wt mice, was accompanied by β-arrestin2-mediated desensitization of dopamine D2 receptor (D2R) in a manner prevented by SB-334867 or the D2R antagonist L741 (1.5 mg/Kg, i.p.). These results further support the role of OX-A signaling in the control of neuroadaptive responses, such as compulsive reward-seeking behavior or binge-like consumption of high palatable food, and suggest that aberrant OX-A trafficking to the DA neurons in the VTA of ob/ob mice influences the D2R response at NAc, a main target area of the mesolimbic pathway, via 2-AG/CB1-mediated retrograde signaling. Frontiers Media S.A. 2021-02-04 /pmc/articles/PMC7890184/ /pubmed/33613258 http://dx.doi.org/10.3389/fnsyn.2021.622405 Text en Copyright © 2021 Tunisi, D'Angelo, Fernández-Rilo, Forte, Piscitelli, Imperatore, de Girolamo, Di Marzo and Cristino. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Tunisi, Lea D'Angelo, Livia Fernández-Rilo, Alba Clara Forte, Nicola Piscitelli, Fabiana Imperatore, Roberta de Girolamo, Paolo Di Marzo, Vincenzo Cristino, Luigia Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title | Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title_full | Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title_fullStr | Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title_full_unstemmed | Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title_short | Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice |
title_sort | orexin-a/hypocretin-1 controls the vta-nac mesolimbic pathway via endocannabinoid-mediated disinhibition of dopaminergic neurons in obese mice |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890184/ https://www.ncbi.nlm.nih.gov/pubmed/33613258 http://dx.doi.org/10.3389/fnsyn.2021.622405 |
work_keys_str_mv | AT tunisilea orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT dangelolivia orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT fernandezriloalbaclara orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT fortenicola orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT piscitellifabiana orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT imperatoreroberta orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT degirolamopaolo orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT dimarzovincenzo orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice AT cristinoluigia orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice |